Print this page Facebook Twitter Google+ Email

The Pharmaceutical Benefits Scheme (PBS) and the Gastroenterological Society of Australia (GESA) have published information for health professionals to help them manage the new hepatitis C treatments. This includes national guidelines for the management of hepatitis C based on a consensus statement first published in 2016.

This statement was prepared by an expert panel representing the Gastroenterological Society of Australia (Australian Liver Association), the Australasian Society for Infectious Diseases, the Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine, the Australasian Hepatology Association, Hepatitis Australia and the Royal Australian College of General Practitioners.

The recommendations are updated regularly as new medicines become available.

The links below have been updated to include the new hepatitis C treatment consensus guidelines from September 2018.

From GESA

Right click to download PDFs

From PBS

Right click to download PDFs

From Hepatitis SA

From ASHM

Search Hepatitis SA